COMPASS Pathways plc (CMPS)
- GlobeNewswire
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
LONDON, April 29, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading psychedelic-assisted psychotherapy platform with the largest network of licensed therapists focused on psychedelics in the US, today announced they have entered into a research collaboration agreement to inform the development of a scalable and practical delivery
- GlobeNewswire
Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible
- Insider Monkey
20 Most Depressed Countries in Asia
In this article, we will be taking a look at the 20 most depressed countries in Asia. If you do not want to learn about the Asian depression market, head straight to the 5 Most Depressed Countries in Asia. Overview of the Global and Asian Depression Market The global depression market is a significant sector […]
